How to Buy Amicus Therapeutics Stock

Amicus Therapeutics Inc

Amicus Therapeutics, Inc. , a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases.

Amicus Therapeutics stock last closed at $6.03, down 2.27% from the previous day, and has decreased 43.35% in one year. It has overperformed other stocks in the Biotechnology industry by 0.33 percentage points. Amicus Therapeutics stock is currently +3.79% from its 52-week low of $5.81, and -52.33% from its 52-week high of $12.65.

There are currently 307.93M FOLD shares outstanding. The market cap of FOLD is $1.86B. In the last 24 hours, 4.23M FOLD shares were traded.

How to Buy Amicus Therapeutics Stock

Wondering how to invest in Amicus Therapeutics stock? Here's how.

  1. Decide where to buy Amicus Therapeutics stock: You need to choose an online brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you decide where to buy Amicus Therapeutics stock.
  2. Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
  3. Deposit money your brokerage account: Pick your payment method and add your info.
  4. Research Amicus Therapeutics stock: The Amicus Therapeutics ticker symbol is FOLD. Is Amicus Therapeutics stock a good investment? Should you buy shares of FOLD? How do FOLD's underlying business fundamentals look? Do top analysts think Amicus Therapeutics is a good buy? Why has FOLD's stock price moved recently? (Hint: Our stock market analysis website can help you decide if FOLD is a good stock to buy).
  5. Execute your FOLD trade: Decide if you will purchase FOLD shares at the current market price or use a limit order to purchase FOLD stock at a given price.
  6. Get the latest scoop on your FOLD position: Create a watchlist to key updates about your investment in Amicus Therapeutics shares.

Step 1: Decide where to buy Amicus Therapeutics stock

You will need an online brokerage account to access the NASDAQ market and buy FOLD stock.

A brokerage account enables you to buy and sell a variety of financial instruments, including stocks, bonds, mutual funds, and ETFs.

Our recommended brokerage: eToro

Based on our research, eToro is the best brokerage. Here's why:

  • Invest in stocks with zero commissions: Invest without commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
  • Access to global markets: From Technology to Real Estate, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
  • Social investing: eToro offers a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other financial assets: Such as ETFs and cryptos.

Get $10 towards your purchase of stock by opening an account with eToro today. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open your brokerage account

Now that you've chosen the right brokerage, you need to fill out some personal information so you are able to invest in FOLD stock today.

How to Open a New Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Input your personal details to create a new trading account.
  1. Submit your details by clicking the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit money your brokerage account

Now that you have opened your account on our top ranked stock trading app, you need to deposit funds:

Check out the video below for more details transferring funds into your investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Amicus Therapeutics stock

Once you have decided on the best place to buy Amicus Therapeutics stock, it's very important to evaluate their stock before you invest, so you can wrap your head around the risk as well as the upside.

Amicus Therapeutics Metrics

FOLD Price
$6.03
1w %
-2.11%
1y %
-43.35%
5y %
-45.87%
P/E
-67x
P/B
9.59x
P/S
3.42x
PEG
N/A
Revenue
$543.14M
Earnings
-$29.37M
Fore. Rev. Growth
17.41%
Fore. Earn. Growth
N/A
Market Cap
$1.86B
Next Earnings
N/A
Next Dividend
N/A

FOLD Due Diligence Checks

WallStreetZen was built to help part-time investors do better fundamental analysis in less time.

You can see all of the due diligence checks on FOLD's stock page.

How is FOLD stock valued?

You can use many financial metrics, analyses, models, and charts to gauge FOLD's true value.

Using relative valuations metrics:

  • FOLD may be overvalued based on its P/B ratio of 9.59x, relative to Biotechnology industry P/B ratio of 4.66x

You can do more valuation analysis on FOLD's stock here.

FOLD Financial Summary

Pros:

  • There are more short-term assets than short-term liabilities on the FOLD balance sheet.
  • FOLD profit margin has gone up from -34.7% to -5.4% in the past year.
  • There are more short-term assets than long-term liabilities on the FOLD balance sheet.

Cons:

  • Total FOLD debt is higher than 5 years ago, relative to shareholder equity.
  • FOLD earnings of $45.40M is not enough to cover its interest payments.
  • FOLD's operating cash flow of $3.56M allows it to safely service it's debt of $443.47M.
  • FOLD has a relatively high debt to equity ratio of 3.08.

Is it a good time to buy FOLD stock, according to analysts?

Out of 4 Wall Street analysts who give recommendations on FOLD, the consensus analyst rating on Amicus Therapeutics is a Strong Buy

It's important to note that analyst forecasts are not stock recommendations, nor are they financial advice.

You can dive deeper into what analysts are forecasting on the Amicus Therapeutics stock forecast page.

FOLD Trading Indicators

SMA10
6.11
SMA20
6.2
SMA50
6.53
SMA100
7.86
SMA200
9.16
MACD
-0.15
MACD Signal
-0.19
MACD Histogram
0.04
RSI
42.14
Stochastic %K
44.44
Stochastic %D
40.96
StochRSI %K
83.62
StochRSI %D
84.02

FOLD Earnings

Last year, FOLD revenue was $543.14M. Over the last five year, FOLD's revenue has grown by 21.08% per year. This was slower than the Biotechnology industry average of 43.24%.

Dig into FOLD's earnings and revenue performance here.

Who is buying/selling FOLD?

In the last year, executives and large shareholders at FOLD have sold more shares than they have bought.

Bradley L. Campbell, President and CEO of FOLD, was the latest FOLD insider to sell. They sold $119,037.50 worth of FOLD shares on Mar 15, 2025.

Get more info about who owns FOLD stock here.

Can I rely on FOLD as an income stream?

No, Amicus Therapeutics doesn't provide an income stream by paying out dividends.

What do other investors have to say about FOLD?

One of the major reasons eToro is our favorite brokerage is because of its social trading community.

Click below to learn what other traders have to say.

Step 5: Execute your FOLD trade

There are two main order types:

  • Market order: A market order is an order to buy or sell a security at the best possible price.
    Market orders are mostly fine for most investors.
  • Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
    If you want to make sure you're buying or selling at a given price, place a limit order.

Click the Open button and your broker will execute your order.

If you want more info about buying stocks on eToro, click the how to video below:

Open eToro Account

Step 6: Get the latest scoop on your FOLD position

Now that you own some FOLD shares, you'll want to stay up-to-date on your new shares.

Add FOLD to a watchlist to track your FOLD stock.

FOLD Feed

How to Buy Stock in Amicus Therapeutics

To reiterate, here are the 6 steps you need to take to buy Amicus Therapeutics stock right now:

  1. Decide where to buy Amicus Therapeutics stock
  2. Open your brokerage account
  3. Deposit money your brokerage account
  4. Research Amicus Therapeutics stock
  5. Execute your FOLD trade
  6. Get the latest scoop on your FOLD position

If you require a brokerage, eToro is our favorite venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to monitor your investment in Amicus Therapeutics, add FOLD to your watchlist below.

NASDAQ: FOLD
$6.03-0.14 (-2.27%)
Updated Jun 13, 2025
Open eToro Account
Your capital is at risk.
NASDAQ: FOLD
$6.03-0.14 (-2.27%)
Updated Jun 13, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Amicus Therapeutics share?

As of Jun 13, 2025, it costs $6.03 to buy one share of Amicus Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $3, you can buy 0.498 shares of FOLD.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Amicus Therapeutics stock?

According to 4 Wall Street analysts who monitor Amicus Therapeutics, their consensus recommendation is to buy Amicus Therapeutics stock.

What is the best way to buy Amicus Therapeutics stock?

One way to place an order for Amicus Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.